Home›Search›Experimental Hematology and Oncology

Experimental Hematology and Oncology

BioMed Central Ltd · United Kingdom · Est. 2012

ISSN2162-3619eISSN2162-3619

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total75

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

3.092

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.692

Total Works

879

Total Citations

24,371

2yr Mean Citedness

10.64

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on research in hematology and oncology, with a strong emphasis on the tumor microenvironment, immune responses to cancer, and novel therapeutic strategies. Articles explore the role of immune cells, checkpoints, and signaling pathways in cancer progression and treatment resistance. Therapeutic approaches investigated include immunotherapy, oncolytic viruses, targeted therapies, and cell-based therapies, often in the context of hematologic malignancies and solid tumors.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Fast · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published2012

Annual Volume~ 123 articles / year

StatusActive (last: 2026)

Total Publications879

Publisher OrgBioMed Central

OA Since2011

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~6 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

CLOCKSSBritish LibraryLOCKSSPorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2162-3619 / 2162-3619

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

CLOCKSS, British Library, LOCKSS, Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

HematologyQ1

OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyCancer ResearchOncology

Research Topics (OpenAlex)

CAR-T cell therapy researchAcute Myeloid Leukemia ResearchCancer Immunotherapy and BiomarkersLymphoma Diagnosis and TreatmentImmune Cell Function and InteractionImmunotherapy and Immune ResponsesImmune cells in cancerChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchMultiple Myeloma Research and Treatments